Aktieanalys

Scandion Oncology: Outcome of right issue announced - Redeye

{newsItem.title}

Redeye Publicerad: 05 Jul 2022 19:13

Scandion Oncology

Redeye comments on the outcome of Scandion’s rights issue, and we resume our coverage. We adjust our valuation for increased cash and shares outstanding.

Länk till analysen i sin helhet: https://www.redeye.se/research/848074/scandion-oncology-outcome-of-right-issue-announced?utm_source=finwire&utm_medium=RSS

Nyheter om Scandion Oncology

Läses av andra just nu

Om aktien Scandion Oncology

Senaste nytt